2801c Medicines infusion injection
Originaltitel der Bekanntmachung
Norway – Medical equipments, pharmaceuticals and personal care products – 2801c Medicines infusion injection
Opportunity Score
Warum diese Bewertung?
Chance
35 / 100
Komplexität
25 / 100
Risikofaktoren
Absence of estimated value, award criteria, and eligibility requirements increases uncertainty and risk of wasted effor...
Structured data indicates EU funding, but XML notice states no EU funds. This could affect contract terms or budget.
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Überblick
Moderate opportunityWichtige Fakten
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Jan 2030
- Procurement of various medicines for use in infusion injections
- Coverage for four regional health authorities: Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF, Helse Nord RHF
Vollständige Zusammenfassung anzeigen
This tender by Sykehusinnkjøp HF, on behalf of the four Norwegian regional health authorities, seeks to procure various medicines for infusion injections. It is structured as a single-lot framework agreement for supplies, with an open procedure. The estimated value is not disclosed, and key details on award criteria, selection criteria, and required documents are missing from the notice. Submission is electronic via the provided URL, with a deadline of 17 September 2026.
Risiken
Absence of estimated value, award criteria, and eligibility requirements increases uncertainty and risk of wasted effor...
Structured data indicates EU funding, but XML notice states no EU funds. This could affect contract terms or budget.
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Contract as framework agreement
- Supplies nature
- EU funded (as per structured data, but XML notice indicates no EU funds - inconsistency)
Anforderungen können unvollständig sein.
Auftraggeber
Ort
VADSØ, NOR
Auftraggeberprofil
Kennung
916879067
Tätigkeit
Health
Lose (1)
LOT-0001
2801c Medicines infusion injection
Procurement of various medicines for use in infusion injections, covering the four regional health authorities in Norway. Framework agreement for supplies.
Ort
Dauer
Kategorie
Frist
Zuschlagsdetails
Sykehusinnkjøp HF, division Pharmaceuticals, shall procure various medicines for use in infusion injections. The contracting authorities for this competition are the four regional health authorities in Norway, Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF.
Zusätzliche CPV-Codes
Hinweis zum Wert
Originale TED-Daten anzeigen
Originale TED-Beschreibung
Sykehusinnkjøp HF, division Pharmaceuticals, shall procure various medicines for use in infusion injections. The contracting authorities for this competition are the four regional health authorities in Norway, Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF.
Vergabedetails
- Veröffentlichungsdatum
- 23 Jun 2026
- Sprachen
- English, Norwegian
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 431517-2026
Dokumente (1)
Ähnliche Ausschreibungen
Poland – Various medicinal products – Dostawa produktów leczniczych, nr PN-127/26/TM
Belgium – Various medicinal products – Leveren van paracetamol oplossing voor intraveneus gebruik voor de ziekenhuisapotheek
Belgium – Anaesthetics – LEVEREN VAN ROCURONIUM 50 MG/ 5 ML VOOR INTRAVENEUS GEBRUIK
France – Various medicinal products – FOURNITURE DE MEDICAMENTS RADIOPHARMACEUTIQUES (TEP et SCINTI) ______________________________________________________________________
Belgium – Medicinal products for the respiratory system – LEVEREN VAN PIRFENIDONE 267 mg en 801 mg (filmomhulde) tabletten
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Opportunity Score
Warum diese Bewertung?
Chance
35 / 100
Komplexität
25 / 100
Risikofaktoren
Absence of estimated value, award criteria, and eligibility requirements increases uncertainty and risk of wasted effor...
Structured data indicates EU funding, but XML notice states no EU funds. This could affect contract terms or budget.
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications